Bleunomics

Curated by Signal

Provider of computationally-derived drug discovery pipelines targeting clinical levels

Overview

Provider of computationally-derived drug discovery pipelines targeting clinical levels. The company is focused on therapeutics and DNA computing, specializing in extensive data analysis and visualization techniques for genomic data.

Key facts

Founded: 2019
Headquarters: Boston, United States
Stage: Sign up to view
Industry: Health Technology

Business model

11 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Hi Neo
Platform offering hospital price transparency
Health TechnologyNew York City, United States
EverHealth
Cloud-based EMR management tool for providers
Health TechnologyDenver, United States
LivProactiv
Diabetes management solution
Health TechnologyHallandale Beach, United States

About Bleunomics

What does Bleunomics do?

Provider of computationally-derived drug discovery pipelines targeting clinical levels.

Where is Bleunomics headquartered?

Bleunomics is headquartered in Boston, United States.

When was Bleunomics founded?

Bleunomics was founded in 2019.

Which sector is Bleunomics in?

Bleunomics operates in Health Technology.

Who are Bleunomics's competitors?

Companies similar to Bleunomics include Hi Neo, EverHealth, and LivProactiv.